Company news
Sareum Holdings plc news in 2023
Sareum Holdings plc's news releases, calls and decks from 2023, newest first.
Drawdown of Equity Prepayment Facility
November 23, 2023
Initiation of food effects study for SDC-1801
November 9, 2023
Director Dealings
November 8, 2023
Sareum enhances SDC-1801 patent protection
November 3, 2023
Exercise of Share Options and Director Dealings
November 2, 2023
Final Results for the Year Ended 30 June 2023
October 9, 2023
Director's Dealing
September 6, 2023
Director Dealing
September 5, 2023
Dosing of first subjects in MAD Phase 1a trial
September 4, 2023
Update on financial and operational progress
August 16, 2023
Equity Prepayment Facility of up to £5 million
August 3, 2023
Sareum Announces Two New Granted Patents
June 26, 2023
Dosing commences in Phase 1a trial of SDC-801
June 6, 2023
Phase 1a clinical trial for SDC-1801
May 18, 2023
Approval to initiate Phase 1 clinical trial
May 5, 2023
Half-Year Report
March 22, 2023
Update on SDC-1801
March 15, 2023
Notice of Half-Year Results
March 15, 2023